Cronos Group (CRON.US). Marijuana stock.
The company’s shares broke the short-term downward wedge, holding more than 200 – the average average and a break and closing above 50 – the average. Price managed to break through successfully and level 23.6 at Fibonacci. Shares remain in long-term upward trend. CCI and RSI confirm the purchase signal.
The company released better-than-expected reports. Merrill Lynch has updated its expectations for the company with a buy-in rating and a $ 27 target. The company is also highly oriented to the cannabis market and the development of such products. The niche is extremely potential and undeveloped.
Trader Martin Nikolov